Objectives: To assess whether increasing radioactive iodine dose can increase treatment efficacy in Graves' disease.
Methods: A prospective study was conducted, including 106 patients receiving 20 mCi (740 MBq) radioactive iodine (RAI), compared with a retrospective data, including 113 patients receiving 10-15 mCi (370-555 MBq) RAI. Remission and failure rates were evaluated at 6 months post-RAI. Statistical analysis was performed using logistic regression and Kaplan-Meier curves.
Results: Patients receiving 20 mCi RAI demonstrated a significantly higher remission rate compared to the 10-15 mCi group (82.1% vs 66.4%, p = 0.009). Median time to remission was shorter in the 20 mCI group (3 vs 4 months, p = 0.002). Hypothyroidism at 6 months was more prevalent in the 20 mCi group (67% vs 53%, p = 0.03). Larger thyroid size (> 60 g) was associated with treatment failure (p = 0.02).
Conclusions: Higher dosage (20 mCi) RAI showed superior efficacy in achieving remission compared to lower dosages (10-15 mCi) in Graves' disease treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11044547 | PMC |
| http://dx.doi.org/10.1186/s12902-024-01588-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry
September 2024
Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Background: Mild cognitive impairment (MCI) confers a high annual risk of 10-15 % of conversion to Alzheimer's disease (AD) dementia. MRI atrophy patterns derived from automated ROI analysis, particularly hippocampal subfield volumes, were reported to be useful in diagnosing early clinical stages of Alzheimer's disease.
Objective: The aim of the present study was to combine automated ROI MRI morphometry of hippocampal subfield volumes and cortical thickness estimates using FreeSurfer 6.
A multimodal machine learning model for predicting dementia conversion in Alzheimer's disease.
Sci Rep
May 2024
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 10 63-ro, Yeongdeungpo-gu, Seoul, 07345, Korea.
Article Synopsis
- Alzheimer's disease (AD) is a major cause of dementia, affecting 60-70% of dementia patients, with mild cognitive impairment (MCI) serving as a precursor stage where about 10-15% of individuals transition to AD each year.
- This study analyzed data from 196 subjects to identify the best combination of imaging features and machine learning models to predict the conversion from MCI to AD over a four-year follow-up, finding that 24% of patients progressed to AD.
- The Gradient Boosting Machine (GBM) model proved to be the most reliable, demonstrating that omitting certain imaging features can enhance prediction accuracy, thereby aiding clinicians in early diagnosis and treatment planning for MCI patients.
Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
BMC Endocr Disord
April 2024
Division of Endocrinology, Department of Internal Medicine, Phrapokklao Hospital, No 38, Leab Neon Road, Mueang, Chanthaburi, 22000, Thailand.
Objectives: To assess whether increasing radioactive iodine dose can increase treatment efficacy in Graves' disease.
Methods: A prospective study was conducted, including 106 patients receiving 20 mCi (740 MBq) radioactive iodine (RAI), compared with a retrospective data, including 113 patients receiving 10-15 mCi (370-555 MBq) RAI. Remission and failure rates were evaluated at 6 months post-RAI.
Measurement of neuropsychiatric symptoms in the older adults with mild cognitive impairment based on speech and facial expressions: a cross-sectional observational study.
Aging Ment Health
May 2024
School of Nursing, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Objectives: To examine the association between speech and facial features with depression, anxiety, and apathy in older adults with mild cognitive impairment (MCI).
Methods: Speech and facial expressions of 319 MCI patients were digitally recorded via audio and video recording software. Three of the most common neuropsychiatric symptoms (NPS) were evaluated by the Public Health Questionnaire, General Anxiety Disorder, and Apathy Evaluation Scale, respectively.
A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study.
EClinicalMedicine
November 2023
School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Background: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder that poses a worldwide public health challenge. A neuroimaging biomarker would significantly improve early diagnosis and intervention, ultimately enhancing the quality of life for affected individuals and reducing the burden on healthcare systems.
Methods: Cross-sectional and longitudinal data (10,099 participants with 13,380 scans) from 12 independent datasets were used in the present study (this study was performed between September 1, 2021 and February 15, 2023).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!